Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.

Eriguchi R, Obi Y, Soohoo M, Rhee CM, Kovesdy CP, Kalantar-Zadeh K, Streja E.

Am J Nephrol. 2019;50(5):361-369. doi: 10.1159/000502998. Epub 2019 Sep 13.


Factors Associated With Withdrawal From Dialysis Therapy in Incident Hemodialysis Patients Aged 80 Years or Older.

Ko GJ, Obi Y, Chang TI, Soohoo M, Eriguchi R, Choi SJ, Gillen DL, Kovesdy CP, Streja E, Kalantar-Zadeh K, Rhee CM.

J Am Med Dir Assoc. 2019 Jun;20(6):743-750.e1. doi: 10.1016/j.jamda.2018.11.030. Epub 2019 Jan 25.


Addressing the gap in clinical research education: Implementation of the Introduction to Clinical Research Training-Japan program.

Moromizato T, Garcia-Larsen V, Soeteman D, Wickner PG, Havens JM, Lund R, Eriguchi R, Tokuda Y, Murata K, Iseki K, Singh AK, Christopher KB.

J Gen Fam Med. 2018 Sep 15;19(6):188-190. doi: 10.1002/jgf2.204. eCollection 2018 Nov. No abstract available.


Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.

Kim T, Streja E, Soohoo M, Rhee CM, Eriguchi R, Kim TW, Chang TI, Obi Y, Kovesdy CP, Kalantar-Zadeh K.

Am J Nephrol. 2017;46(2):120-130. doi: 10.1159/000478735. Epub 2017 Jul 14.


Longitudinal Associations among Renal Urea Clearance-Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis.

Eriguchi R, Obi Y, Streja E, Tortorici AR, Rhee CM, Soohoo M, Kim T, Kovesdy CP, Kalantar-Zadeh K.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1109-1117. doi: 10.2215/CJN.13141216. Epub 2017 May 10.


Changes in urine volume and serum albumin in incident hemodialysis patients.

Eriguchi R, Obi Y, Rhee CM, Chou JA, Tortorici AR, Mathew AT, Kim T, Soohoo M, Streja E, Kovesdy CP, Kalantar-Zadeh K.

Hemodial Int. 2017 Oct;21(4):507-518. doi: 10.1111/hdi.12517. Epub 2016 Nov 25.


What Is Known and Unknown About Twice-Weekly Hemodialysis.

Obi Y, Eriguchi R, Ou SM, Rhee CM, Kalantar-Zadeh K.

Blood Purif. 2015;40(4):298-305. doi: 10.1159/000441577. Epub 2015 Nov 17.


Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism.

Yamada S, Tokumoto M, Taniguchi M, Toyonaga J, Suehiro T, Eriguchi R, Fujimi S, Ooboshi H, Kitazono T, Tsuruya K.

Ther Apher Dial. 2015 Aug;19(4):367-77. doi: 10.1111/1744-9987.12292. Epub 2015 Apr 7. Erratum in: Ther Apher Dial. 2016 Jun;20(3):329.


Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study.

Eriguchi R, Taniguchi M, Ninomiya T, Hirakata H, Fujimi S, Tsuruya K, Kitazono T.

J Nephrol. 2015 Apr;28(2):217-25. doi: 10.1007/s40620-014-0121-9. Epub 2014 Jul 31.


Chronic hemodialysis patients with visceral obesity have a higher risk for cardiovascular events.

Moriyama Y, Eriguchi R, Sato Y, Nakaya Y.

Asia Pac J Clin Nutr. 2011;20(1):109-17.


Kienböck's disease: unusual cause of acute onset wrist pain in a dialysis patient.

Yamada S, Eriguchi R, Toyonaga J, Taniguchi M, Fujimi S, Tsuruya K.

Intern Med. 2011;50(5):467-9. Epub 2011 Mar 1.


Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl.

Eriguchi R, Umakoshi J, Tominaga Y, Sato Y.

NDT Plus. 2008 Aug;1(4):218-220. Epub 2008 May 25. No abstract available.


[Control of calcium and phosphate in hemodialysis patients].

Eriguchi R, Takei S, Satou Y.

Clin Calcium. 2005 Sep;15 Suppl 1:132-7; discussion 137. Japanese. Erratum in: Clin Calcium. 2006 Feb;16(2):149-52.


Supplemental Content

Loading ...
Support Center